Rasio tanggungan utang jangka dawa marang modal BrainsWay Ltd (BWAY)

BrainsWay Ltd. (BWAY) develops neurostimulation systems, incorporating energy-saving components and recycled plastics to comply with ESG standards. Despite prolonged equipment procurement and insurance complexities in the US, expansion into foreign markets offsets these threats. The business relies on the implementation of magnetic brain stimulation technologies and the expansion of the list of FDA-approved diagnoses. This chart shows the market price at the 0.07 metric, confirming the asset's current price action.

This indicator is indispensable for stress-testing debt loads and assessing the issuer's financial stability over a long-term horizon. The ratio of liabilities with a maturity of over one year to equity determines the business's dependence on borrowed financing, which, in the long-term debt-to-net assets ratio, reflects the ability of BrainsWay Ltd. (BWAY) to invest in the development of its proprietary Deep TMS systems without a critical risk of bankruptcy.